Inadequate growth hormone suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' growth hormone levels.

John Lindsay

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)475-476
Number of pages2
JournalClinical Endocrinology
Issue number4
Publication statusPublished - Apr 2006

ASJC Scopus subject areas

  • Endocrinology

Cite this